These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25524408)

  • 1. Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model.
    Yao G; Han X; Hao T; Huang Q; Yu T
    Neurosci Lett; 2015 Feb; 587():29-34. PubMed ID: 25524408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tibetan medicine Ru-yi-Zhen-bao Pills exhibits anti-migraine effect through mediating PAG anti-nociceptive channel.
    Luo YM; Ren XQ; Yang XQ; Song HR; Li R; Gao MH; Li YR; Zhou RR; Ma L; Zhang SJ; Dong RJ; Ge DY; Wang CG; Ren QJ; Tao XH
    J Ethnopharmacol; 2020 Mar; 249():112437. PubMed ID: 31794788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].
    Stepień A; Jagustyn P; Trafny EA; Widerkiewicz K
    Neurol Neurochir Pol; 2003; 37(5):1013-23. PubMed ID: 15174248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
    Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT
    Edvinsson JCA; Maddahi A; Christiansen IM; Reducha PV; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA
    J Headache Pain; 2022 Feb; 23(1):26. PubMed ID: 35177004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of female sex hormones augments PGE2 and CGRP levels within midbrain periaqueductal gray.
    Wang D; Zhao J; Wang J; Li J; Yu S; Guo X
    J Neurol Sci; 2014 Nov; 346(1-2):107-11. PubMed ID: 25175853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
    Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.
    Gupta S; Villalón CM
    Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models.
    Bhatt DK; Gupta S; Jansen-Olesen I; Andrews JS; Olesen J
    Cephalalgia; 2013 Jan; 33(2):87-100. PubMed ID: 23155193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
    Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
    Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats.
    Kooshki R; Abbasnejad M; Esmaeili-Mahani S; Raoof M; Sheibani V
    Neuropharmacology; 2020 Nov; 178():107981. PubMed ID: 32745488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
    Durham PL; Masterson CG
    Headache; 2013 Jan; 53(1):67-80. PubMed ID: 23095108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Electroacupuncture on Expression of 5-HT
    Pei P; Chen HZ; Wang YX; Yang WM; Liu L; Wang LP
    Zhen Ci Yan Jiu; 2017 Dec; 42(6):510-3. PubMed ID: 29318857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].
    Ikemoto F; Toru T; Aijima H; Natsumeda Y
    Nihon Yakurigaku Zasshi; 2004 Apr; 123(4):295-302. PubMed ID: 15056946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist.
    Kaiser EA; Kuburas A; Recober A; Russo AF
    J Neurosci; 2012 Oct; 32(44):15439-49. PubMed ID: 23115181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin in trigeminal ganglia of female rodents: relevance to menstrual migraine.
    Berman NE; Puri V; Chandrala S; Puri S; Macgregor R; Liverman CS; Klein RM
    Headache; 2006 Sep; 46(8):1230-45. PubMed ID: 16942467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.
    Mannix LK
    Expert Opin Pharmacother; 2008 Apr; 9(6):1001-11. PubMed ID: 18377342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
    Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
    Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.